Conservative Intervention of Femoroacetabular Impingement Syndrome

February 3, 2017 updated by: Duke University

Conservative Intervention of Femoroacetabular Impingement Syndrome: A Randomized Controlled Trial

  1. Purpose: 1) compare three conservative treatment approaches for subjects with femoroacetabular impingement syndrome (FAI), and 2) analyze functional outcome comparatively across groups.
  2. Interventions will be provided based on randomized assignment. Group 1 will receive treatment based on identified impairments and treated twice weekly to address said impairments with hip manual therapy and exercise, as well as a prescriptive exercise for strengthening and mobility of the hip. Group 2 will receive only the prescriptive exercise program. Group 3 will be a control group (supervised neglect)
  3. Primary outcomes data analysis will involve a mixed design (repeated measures) ANOVA for assessment of the primary outcome measure of the HAGOS. Secondary analyses will include chi square analyses (PASS, surgery at 6 months, adverse events), ANCOVA (PPMs, and expectations measures), or other appropriate comparative measures. None of the proposed treatment is considered outside of 'standard of practice'.

Study Overview

Study Type

Interventional

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 60 years (ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Individuals age 18 to 60 years,
  • diagnosed with FAI by an orthopedic surgeon and exhibiting
  • hip/groin symptoms for at least 3 months (symptomatic); and
  • signs, symptoms and imaging findings conducive to FAI will be recruited from a surgical practice of an orthopedic surgeon in Durham, North Carolina.

Exclusion Criteria:

  • subjects that have radiographic evidence of hip osteoarthritis that is more than mild in severity defined as Tonnis >grade 1 or Kellgren-Lawrence >2;
  • have other concurrent injury/conditions that will affect their ability to participate in the rehabilitation program and/or assessment procedures;
  • exhibit hip dysplasia (center edge angle <20 degrees on AP radiograph
  • are unable to attend a study physiotherapist or participate in the rehabilitation program if randomized to the PT group;
  • are unable to understand English.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: SINGLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Education, exercise and manual therapy

One group will receive education and advice, manual therapy that is applied toward the impairments of the subject, a prescription of progressive rehabilitation exercises designed to strengthen weakened muscle groups and stretch joint movements that demonstrate range of motion limitations. Treatment is based on clinical presentation and identification of impairments by the treating clinician. Subjects will be seen twice weekly for 4 to 6 weeks, depending on the progression.

All three groups will receive standardized education on the current state of FAI interventions (with both conservative and surgical care). All interventions will be provided by licensed physical therapists that are named as investigators in this study.

Hip joint and spine manual therapy techniques applied toward the impairments of the subject.
All three groups will receive standardized education on the current state of FAI interventions (with both conservative and surgical care).
ACTIVE_COMPARATOR: Education and exercise

Group will receive a prescriptive intervention designed to strengthen the hip and surrounding regions as well as improve flexibility of the lower extremity. This group will not receive additional physiotherapy management but will be schedule bi-weekly to review the home exercises and to receive appropriate educational support.

All three groups will receive standardized education on the current state of FAI interventions (with both conservative and surgical care). All interventions will be provided by licensed physical therapists that are named as investigators in this study.

All three groups will receive standardized education on the current state of FAI interventions (with both conservative and surgical care).
Prescriptive exercise program of self-mobilization and/or strengthening program to address impairments of the subject.
PLACEBO_COMPARATOR: Supervised neglect

Group will receive supervised neglect. We will monitor this group for changes or emergent situations but no formal care will be provided.

All three groups will receive standardized education on the current state of FAI interventions (with both conservative and surgical care). All interventions will be provided by licensed physical therapists that are named as investigators in this study.

All three groups will receive standardized education on the current state of FAI interventions (with both conservative and surgical care).
Monitoring of group without formal intervention.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Did subject elect to undergo surgery?
Time Frame: up to 6 months after intervention
Determination of whether the subject had surgery for femoroacetabular impingement or not
up to 6 months after intervention

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Stanford Expectations of Treatment Scale (SETS)
Time Frame: initial visit, 4 to 6 weeks after initial visit, and 6 months after initial visit
subject expectation of treatment
initial visit, 4 to 6 weeks after initial visit, and 6 months after initial visit
Change in Patient Acceptable Symptom State (PASS)
Time Frame: initial visit, 4 to 6 weeks after initial visit, and 6 months after initial visit
subject acceptance of what their current symptom state is
initial visit, 4 to 6 weeks after initial visit, and 6 months after initial visit
Change in numeric pain rating scale
Time Frame: initial visit, 4 to 6 weeks after initial visit, and 6 months after initial visit
initial visit, 4 to 6 weeks after initial visit, and 6 months after initial visit
Change in Hip and Groin Outcome Score
Time Frame: initial visit, 4 to 6 weeks after initial visit, and 6 months after initial visit
initial visit, 4 to 6 weeks after initial visit, and 6 months after initial visit
Change in Single leg stance (SLS)
Time Frame: initial visit, 4 to 6 weeks after initial visit, and 6 months after initial visit
measure of single leg balance and stability
initial visit, 4 to 6 weeks after initial visit, and 6 months after initial visit
Change in Lower Quarter Y Balance Test (YBT-LQ)
Time Frame: initial visit, 4 to 6 weeks after initial visit, and 6 months after initial visit
measure of single leg balance, strength and coordination
initial visit, 4 to 6 weeks after initial visit, and 6 months after initial visit
Change in Single Leg Anteroposterior Hop
Time Frame: initial visit, 4 to 6 weeks after initial visit, and 6 months after initial visit
Measure of single leg balance, strength, power and coordination
initial visit, 4 to 6 weeks after initial visit, and 6 months after initial visit
Change in Standing Hip Internal Rotation Range-of-Motion
Time Frame: initial visit, 4 to 6 weeks after initial visit, and 6 months after initial visit
Measure of single leg weight-bearing range of motion
initial visit, 4 to 6 weeks after initial visit, and 6 months after initial visit
Change in Complications/Adverse Events of assigned treatment
Time Frame: initial visit, 4 to 6 weeks after initial visit, and 6 months after initial visit
initial visit, 4 to 6 weeks after initial visit, and 6 months after initial visit

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

March 1, 2016

Primary Completion (ANTICIPATED)

March 1, 2018

Study Completion (ANTICIPATED)

March 1, 2018

Study Registration Dates

First Submitted

March 8, 2016

First Submitted That Met QC Criteria

March 8, 2016

First Posted (ESTIMATE)

March 11, 2016

Study Record Updates

Last Update Posted (ESTIMATE)

February 6, 2017

Last Update Submitted That Met QC Criteria

February 3, 2017

Last Verified

February 1, 2016

More Information

Terms related to this study

Other Study ID Numbers

  • Pro00069234

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Femoroacetabular Impingement

Clinical Trials on Manual therapy

Subscribe